Related Experiment Video
Updated: Dec 31, 2025

Single-cell RNA Sequencing and Analysis of Human Pancreatic Islets
Published on: July 18, 2019
Comprehensive Proteomics Analysis of Stressed Human Islets Identifies GDF15 as a Target for Type 1 Diabetes
Ernesto S Nakayasu1, Farooq Syed2, Sarah A Tersey2
1Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Abstract:
Type 1 diabetes (T1D) results from the progressive loss of β cells, a process propagated by pro-inflammatory cytokine signaling that disrupts the balance between pro- and anti-apoptotic proteins. To identify proteins involved in this process, we performed comprehensive proteomics of human pancreatic islets treated with interleukin-1β and interferon-γ, leading to the identification of 11,324 proteins, of which 387 were significantly regulated by treatment. We then tested the function of growth/differentiation factor 15 (GDF15), which was repressed by the treatment. We found that GDF15 translation was blocked during inflammation, and it was depleted in islets from individuals with T1D. The addition of exogenous GDF15 inhibited interleukin-1β+interferon-γ-induced apoptosis of human islets. Administration of GDF15 reduced by 53% the incidence of diabetes in NOD mice. Our approach provides a unique resource for the identification of the human islet proteins regulated by cytokines and was effective in discovering a potential target for T1D therapy.
Insights
Growth/differentiation factor 15 (GDF15) protects against inflammation-induced beta cell death in type 1 diabetes (T1D). Supplementing GDF15 reduced T1D incidence in mice, identifying it as a potential therapeutic target.
Area of Science:
- Immunology
- Endocrinology
- Proteomics
Background:
- Type 1 diabetes (T1D) involves progressive loss of pancreatic beta cells due to inflammatory cytokine signaling.
- This signaling disrupts the balance of apoptosis-related proteins within beta cells.
Purpose of the Study:
- To identify proteins regulated by inflammatory cytokines in human pancreatic islets.
- To investigate the role of growth/differentiation factor 15 (GDF15) in T1D pathogenesis and its therapeutic potential.
Main Methods:
- Comprehensive proteomics analysis of human pancreatic islets treated with interleukin-1β and interferon-γ.
- Functional assays to assess the impact of GDF15 on apoptosis and in vivo efficacy in a mouse model of T1D.
Main Results:
- Proteomics identified 387 significantly regulated proteins, including repressed GDF15.
- GDF15 translation was blocked during inflammation and GDF15 was depleted in T1D islets.
- Exogenous GDF15 inhibited cytokine-induced apoptosis in human islets and reduced diabetes incidence by 53% in NOD mice.
Conclusions:
- Cytokine-regulated protein networks in human islets were identified.
- GDF15 is a key protective factor against beta cell apoptosis in T1D and a promising therapeutic target.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Diabetes Mellitus: Type 2 and Gestational

